Safety Shot launching clinical trial to measure effect of its drink on blood alcohol levels
Safety Shot Inc.’s stock SHOT was down 5% in in premarket trading on Friday after the company said it started a clinical trial to measure the effects of its Safety Shot drink on blood and breath alcohol. The product is designed as a nutraceutical functional beverage that accelerates the body’s breakdown of alcohol while aiding in recovery and rehydration, the company said. The study includes a double-blinded placebo-controlled test in 36 participants to measure the amount of alcohol in the blood and breath, together with indices of alcohol effects. The company said it plans to launch business-to-business sales of Safety…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In